As part of our rare disease focus month we interview Oliver Timmis of the AKU society on how we can increase recognition of rare diseases such as AKU. There are approximately 7000 rare diseases and ...
(MENAFN- GlobeNewsWire - Nasdaq) The Alkaptonuria Therapeutics Market is driven by advancements in rare disease treatments, with a focus on nitisinone therapy and supportive care. Growing awareness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback